Skip to main content

Advertisement

Log in

Synthesis and evaluation of chromone-2-carboxamide derivatives as cytotoxic agents and 5-lipoxygenase inhibitors

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

In the present study, we prepared a series of 21 chromone carboxamide derivatives bearing diverse amide side chains. Their potency to inhibit the proliferation of breast (MCF-7), ovarian (OVCAR and IGROV), and colon (HCT-116) cancer cell lines, was evaluated in vitro using the MTT assay. Among these compounds, 13 showed promising cytotoxic activity against at least one cancer cell line with IC50 in the range 0.9–10 μM. Our compounds were also screened for their anti-inflammatory activity as putative inhibitors of 5-lipoxygenase.

Structure-activity relationships studies on our chromone carboxamide derivatives revealed that the presence of a 6-fluoro substituent on the chromone nucleus (R1) or propyl and 3-ethylphenyl groups on the amide side chain (R2) has a positive impact on the cytotoxic activity. In terms of the anti-inflammatory activity, hydrophilic chromone carboxamide derivatives showed greater 5-lipoxygenase inhibition.

The physico-chemical properties of chromone carboxamides are in accordance with the general requirements of drug development process and ligand efficiency values allow further structure optimization, with compound 4b as a lead.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1

Similar content being viewed by others

References

  • Abad-Zapatero C (2007) Ligand efficiency indices for effective drug discovery. Expert Opin Drug Dis 2:469–488

    Article  CAS  Google Scholar 

  • Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: How hot is the link? Biochem Pharmacol 72(11):1605–1621

    Article  CAS  PubMed  Google Scholar 

  • Auffret G, Labaied M, Frappier F, Rasoanaivo P, Grellier P, Lewin G (2007) Synthesis and antimalarial evaluation of a series of piperazinyl flavones. Bioorg Med Chem Lett 17(4):959–963

    Article  CAS  PubMed  Google Scholar 

  • Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22(1):33–40

    Article  CAS  PubMed  Google Scholar 

  • Barve V, Ahmed F, Adsule S, Banerjee S, Kulkarni S, Katiyar P, Anson CE, Powell AK, Padhye S, Sarkar FH (2006) Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. J Med Chem 49(13):3800–3808

    Article  CAS  PubMed  Google Scholar 

  • Baylac S, Racine P (2003) Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int J Aromather 13(2-3):138–142

    Article  Google Scholar 

  • Bekir J, Mars M, Souchard JP, Bouajila J (2013) Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food Chem Toxicol 55:470–475

    Article  CAS  PubMed  Google Scholar 

  • Bhatnagar S, Sahi S, Kackar P, Kaushik S, Dave MK, Shukla A, Goel A (2010) Synthesis and docking studies on styryl chromones exhibiting cytotoxicity in human breast cancer cell line. Bioorg Med Chem Lett 20(16):4945–4950

    Article  CAS  PubMed  Google Scholar 

  • Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the human development index (2008–2030): A population-based study. Lancet Oncol 13(8):790–801

    Article  PubMed  Google Scholar 

  • Budzisz E, Graczyk-Wojciechowska J, Zieba R, Nawrot B (2002) A new series of 2-substituted 3-phosphonic derivatives of chromone. Part II. Synthesis, in vitro alkylating and in vivo antitumour activity. New J Chem 26(12):1799–1804

    Article  CAS  Google Scholar 

  • do Rocio Andrade Pires A, Lecerf-Schmidt F, Guragossian N, Pazinato J, Gozzi GJ, Winter E, Valdameri G, Veale A, Boumendjel A, Di Pietro A, Pérès B (2016) New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2. Eur J Med Chem 122:291–301

    Article  Google Scholar 

  • Ellis GP, Shaw D (1972) Benzopyrones. 7. Synthesis and antiallergic activity of some 2-(5-tetrazolyl)chromones. J Med Chem 15(8):865–867

    Article  CAS  PubMed  Google Scholar 

  • Gaspar A, Matos MJ, Garrido J, Uriarte E, Borges F (2014) Chromone: a valid scaffold in medicinal chemistry. Chem Rev 114(9):4960–4992

    Article  CAS  PubMed  Google Scholar 

  • Gaspar A, Reis J, Kachler S, Paoletta S, Uriarte E, Klotz K-N, Moro S, Borges F (2012) Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. Biochem Pharmacol 84(1):21–29

    Article  CAS  PubMed  Google Scholar 

  • Gaspar A, Reis J, Matos MJ, Uriarte E, Borges F (2012) In search for new chemical entities as adenosine receptor ligands: Development of agents based on benzo-g-pyrone skeleton. Eur J Med Chem 54(0):914–918

    Article  CAS  PubMed  Google Scholar 

  • Gaspar A, Silva T, Yanez M, Vina D, Orallo F, Ortuso F, Uriarte E, Alcaro S, Borges F (2011) Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. J Med Chem 54(14):5165–5173

    Article  CAS  PubMed  Google Scholar 

  • Gaspar A, Teixeira F, Uriarte E, Milhazes N, Melo A, Cordeiro MNDS, Ortuso F, Alcaro S, Borges F (2011) Towards the discovery of a novel class of monoamine oxidase inhibitors: structure–property–activity and docking studies on chromone amides. Chem Med Chem 6(4):628–632

    Article  CAS  PubMed  Google Scholar 

  • Hopkins, AL, Keserü, GM, Leeson, PD, Rees DC, and Reynolds CH (2014) Nature Rev 13: 105-121.

  • Keri RS, Budagumpi S, Pai RK, Balakrishna RG (2014) Chromones as a privileged scaffold in drug discovery: A review. Eur J Med Chem 78(0):340–374

    Article  CAS  PubMed  Google Scholar 

  • Khan KM, Ambreen N, Mughal UR, Jalil S, Perveen S, Choudhary MI (2010) 3-Formylchromones: potential antiinflammatory agents. Eur J Med Chem 45(9):4058–4064

    Article  CAS  PubMed  Google Scholar 

  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 23:3–25

    Article  CAS  Google Scholar 

  • Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2):55–63

    Article  CAS  PubMed  Google Scholar 

  • Nam DH, Lee KY, Moon CS, Lee YS (2010) Synthesis and anticancer activity of chromone-based analogs of lavendustin A. Eur J Med Chem 45(9):4288–4292

    Article  CAS  PubMed  Google Scholar 

  • Pan S-T, Li Z-L, He Z-X, Qiu J-X, Zhou S-F (2016) Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 43:723–737

    Article  CAS  PubMed  Google Scholar 

  • Payard M (1973) Nouveau mode de préparation du chlorure d’acide chromone carboxylique-2. Bull Soc Chim Fr 7-8:2392–2394

    Google Scholar 

  • Payard M, Paris J, Tronche P (1974) Synthèse et dissociation d’acides chromone-carboxyliques-2 et d’acides chromone-carbohydroxamiques-2. Bull Soc Chim Fr 16(3):157

    Google Scholar 

  • Redda KK, Gangapuram M, Ghaffari MA, Eyunni S (2014) Synthesis of substituted chromone-2-phenylcarboxamides as anti-breast cancer agents. Cancer Res 74(19):1

    Google Scholar 

  • Shimizu T, Radmark O, Samuelsson B (1984) Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc Natl Acad Sci U.S.A. 81(3):689–693

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Soumaoro LT, Iida S, Uetake H, Ishiguro M, Takagi Y, Higuchi T, Yasuno M, Enomoto M, Sugihara K (2006) Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol 12(39):6355–6360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thanigaimalai P, Le Hoang TA, Lee K-C, Sharma VK, Bang S-C, Yun JH, Roh E, Kim Y, Jung S-H (2010) Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5. Eur J Med Chem 45(6):2531–2536

    Article  CAS  PubMed  Google Scholar 

  • Valdameri G, Genoux-Bastide E, Peres B, Gauthier C, Guitton J, Terreux Rl, Winnischofer SMB, Rocha MEM, Boumendjel A, Di Pietro A (2012) Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein. J Med Chem 55(2):966–970

    Article  CAS  PubMed  Google Scholar 

  • World Health Organization. (2013) Press release no. 223. www.molinspiration.com. Accessed 12 Dec 2013.

Download references

Acknowledgments

We are thankful to Laurent Amielet, Christelle Récochet-Gueriot and Sylvie Cazaux for technical support. We are grateful to the “VLM” association for financial support.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jalloul Bouajila or Salomé El Hage.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bousejra-ElGarah, F., Lajoie, B., Souchard, JP. et al. Synthesis and evaluation of chromone-2-carboxamide derivatives as cytotoxic agents and 5-lipoxygenase inhibitors. Med Chem Res 25, 2547–2556 (2016). https://doi.org/10.1007/s00044-016-1691-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-016-1691-y

Keywords

Navigation